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REVIEW ARTICLE
Beta cell adaptation in pregnancy: a tribute to Claes Hellerstr€om
Jens Høiriis Nielsen
Department of Biomedical Sciences, University of Copenhagen, Denmark
ABSTRACT
Pregnancy is associated with a compensatory increase in beta cell mass. It is well established that soma-
tolactogenic hormones contribute to the expansion both indirectly by their insulin antagonistic effects
and directly by their mitogenic effects on the beta cells via receptors for prolactin and growth hormone
expressed in rodent beta cells. However, the beta cell expansion in human pregnancy seems to occur
by neogenesis of beta cells from putative progenitor cells rather than by proliferation of existing beta
cells. Claes Hellerstr€om has pioneered the research on beta cell growth for decades, but the mecha-
nisms involved are still not clarified. In this review the information obtained in previous studies is reca-
pitulated together with some of the current attempts to resolve the controversy in the field:
identification of the putative progenitor cells, identification of the factors involved in the expansion of
the beta cell mass in human pregnancy, and the relative roles of endocrine factors and nutrients.
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Introduction
Pregnancy represents a unique physiological condition with
profound changes in the hormonal regulation of metabolism
in order to provide sufficient nutrients to the fetus. The
increased food intake increases the demand for insulin, which
is further reinforced by the elevated levels of the somatolac-
togenic hormones (prolactin (PRL), growth hormone (GH), pla-
cental lactogen (PL), and placental growth hormone (GH-V)).
The increased demand for insulin is in normal pregnancy
compensated for by an expansion of the beta cell mass. If
this does not occur, gestational diabetes will develop.
Maternal hyperglycemia is transmitted to the fetus and may
induce a premature insulin secretion resulting in macrosomia
as well as an up to 8-fold increased risk of developing type 2
diabetes (1). It is therefore pertinent to unravel the mecha-
nisms involved in beta cell adaptation to pregnancy. Through
history several investigators have described an increased islet
cell mass in various species, and recently several transcrip-
tional and proteomic characterizations of islets from pregnant
mice and rats have been performed (2–5) (for a review see
Nielsen et al., in press). The scope of this review is to focus
on some of the challenges that still remain in the understand-
ing of the mechanisms involved in beta cell adaptation to
pregnancy.
Role of hormones and nutrients
The first systematic quantitative study of the influence of
pregnancy and lactation on the endocrine pancreas in mice
was published by Claes Hellerstr€om in 1963 (6). The islet
volume at gestational day 20 was increased with about 25%
compared with virgin mice. The numerical distribution of the
islets was asymmetric in both groups, with the majority of
islets in the small size class. In pregnant mice the number of
islets in the large size class was increased. As the ratio
between beta and alpha cells was increased in the pregnant
mice it was concluded that the enlargement of the endocrine
pancreas was mainly due to proliferation of the beta cells. On
day 14 of gestation a significant increase in nuclear size of
the beta cells was found, suggesting an increased insulin syn-
thesis activity. This was not seen at day 20, suggesting that
the glucose load was reduced at the end of the pregnancy or
that the increased number of beta cells was sufficient to
maintain euglycemia. The islet volume was still increased by
25% at day 20. In the rat an increased nuclear size was main-
tained until term, suggesting a sustained high insulin synthe-
sis (7). Increased insulin content and secretory response were
found in islets isolated from late pregnant rats (8,9). Data
compiled from previous studies have shown a marked
increase in the beta cell mass during pregnancy until term
(Figure 1A) (10) and a corresponding increase in pancreatic
insulin content (Figure 1A) (11). Sorenson and collaborators
have demonstrated an increased proliferation of the islet cells
during pregnancy in rats (Figure 1B) (12). Interestingly, there
was a decline in proliferation late in pregnancy. There was
also a decrease in the glucose-stimulated insulin secretion
(GSIS) of the perfused pancreas (Figure 1A) (12). In contrast,
the levels of lactogenic activity reflecting the secretion of the
two placental lactogens PL-1 and PL-2 and pituitary PRL were
high until term (Figure 1B) (12), as was the level of prolactin
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receptor (PRLR) mRNA (Figure 1B) and growth hormone
receptor (GHR) mRNAs (data not shown) in the pancreas of
pregnant rats (13). It has been suggested that the decreased
proliferation may be due to the increased levels of progester-
one (14) and/or glucocorticoids in late pregnancy (15), find-
ings that have been supported by in vitro studies in isolated
islets. It may be that the very high PL levels prevent the
dimerization of the PRLR that is required for signal transduc-
tion. Alternatively, the insulin demand may decrease in late
pregnancy as it has been reported that the blood glucose is
lower close to term (10) and therefore attenuates the meta-
bolic pressure on the beta cells, as already pointed out by
Hellerstr€om in 1963 (6). Restricted carbohydrate intake during
pregnancy has been found to prevent the increased glucose
sensitivity of the beta cells (16), and it has been shown that
insulin treatment or food restriction during pregnancy
reduces the mitogenic effect of PL on beta cells (17,18). Thus,
hyperglycemia seems to play a central role in the proliferative
response of the beta cells, and in fact glucose metabolism in
the beta cells has been demonstrated to promote beta cell
replication (19). The first step in glucose metabolism in beta
cells is glucokinase followed by ATP production and closure
of K/ATP channels and membrane depolarization.
Interestingly, pregnancy is associated with an increase in glu-
cokinase synthesis induced by lactogenic hormones (20),
resulting in a lowering in the threshold for glucose-induced
insulin secretion. Support for the role of glucokinase in beta
cell proliferation comes from studies of activating glucokinase
mutations in patients with congenital neonatal hyperinsuline-
mic hypoglycemia that have hyperplastic islets (21). Thus, the
increased demand for insulin reflected in hyperglycemia may
be compensated for by an increased glucose metabolism in
the beta cells, resulting in increased proliferation and insulin
production. This was already predicted by Hellerstr€om in his
extensive review from 1977 where he stated: ‘It therefore
appears that endocrine factors may be of minor significance
for the islet growth in pregnancy’ (22). The role of the lacto-
genic hormones may be to amplify the stimulating effect of
glucose on beta cell growth and function and to provide
energy for the growth of the fetus.
The challenge of human pregnancy
In human pregnancy there is also an increase in the beta cell
mass, although only few studies have been performed. In
1978 van Assche and co-workers reported five cases with a 2-
fold increase islet mass with an increased number of beta
cells (23). In 2010 Peter Butler and co-workers published 18
cases and found a 1.4-fold increase in the beta cell area
mainly due to an increased number of small islets and not
larger islets and no increase in Ki67-positive beta cells, sug-
gesting that in human pregnancy the beta cell adaptation
occurs by neogenesis of beta cells from progenitor cells
rather than proliferation of existing beta cells (24). The lack of
proliferation of adult human beta cells has been suggested to
be due to low expression of PRL receptors, and in fact gene
expression profiles for mouse and human beta cells have con-
firmed that the expression level of PRLR is 40-fold higher in
mouse beta cells than in human beta cells (25). However, this
may not be the only reason, since a recent study has shown
that over-expression of PRLR in human islets did not result in
a mitogenic response to PRL (26). Whereas activation of
STAT5 has been shown to stimulate proliferation in rat beta
cells (27), activation of human STAT5 was not sufficient to
stimulate human beta cell proliferation, but surprisingly over-
expression of mouse STAT5 did stimulate human beta cell
proliferation (26). Apparently there are species differences in
the post-receptor PRL signaling pathway as well.
Role of beta cell neogenesis
Studies of pregnancy in other species like cow, pig, sheep,
and dog have described the appearance of single beta cells
or small clusters associated with ducts or in the acinar com-
partment, suggesting that neogenesis may contribute to the
increased beta cell mass (see Nielsen et al., in press). Using a
lineage-tracing approach, evidence for the recruitment of
non-beta cell progenitors of beta cells in pregnant mice has
been presented (28). In order to investigate if neogenesis of
beta cells may contribute to the beta cell adaptation in
rodent pregnancy we have recently studied the expression of
neurogenin-3 (Ngn-3) that is transiently expressed during the
embryonic development of the endocrine pancreas (29) in
pancreata of pregnant mice. By immunochemical staining we
found a 3.5-fold increase in expression mainly in the acinar
compartment at pregnancy day 14 where it was 8-fold higher
Figure 1. Changes in beta cell area (b-cell vol) (10), pancreatic insulin content
(INS-panc) (11), and glucose-stimulated insulin secretion (GSIS) (12) (A); and islet
cell proliferation (prolif) (12), circulating lactogenic hormones (lactogen) (12), and
pancreatic prolactin receptor mRNA (PRLR) (13) (B) during pregnancy in rats.
Pregnancy days are shown on the x-axis, and the fraction of the maximal effect
of each parameter is shown on the y-axis. Data from (10–13).
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than in non-pregnant mice (30). Strikingly, this time point
coincides with the maximal expression of Ngn-3 in the
embryonic pancreas (29). The validity of Ngn-3 as a marker of
post-natal beta cell neogenesis is controversial, but even if all
the Ngn-3-positive cells differentiated to beta cells their quan-
titative contribution to the increased beta cell would be small
compared to the contribution from the proliferation of the
existing beta cells. In order to test if circulating factors in
pregnancy contribute to neogenesis we employed the
method for large-scale islet isolation from fetal rat pancreata
in tissue culture developed by Claes Hellerstr€om and co-work-
ers in 1979 (31). At this late fetal period from gestational day
20 to 22 the number of beta cells is more than doubled
mainly by formation of new beta cells from differentiation
and proliferation of precursor cells (32). When we added
serum from pregnant women in third trimester to cultures of
dispersed fetal rat pancreas isolated at gestational day 21.5
we found a marked increase in Ngn-3 mRNA expression, in
particular in the fibroblast-like monolayer (30). We are cur-
rently searching for factors in serum from pregnant women
that influence beta cell growth and function (33).
Concluding remarks
Although much is known about beta cell adaptation to preg-
nancy, there are still unanswered questions that already were
pointed out and investigated by Claes Hellerstr€om decades
ago. What is the relative contribution of the somatolactogenic
hormones and the food intake to the health of the pregnant
woman and her offspring? What is the relative contribution of
proliferation and neogenesis of beta cells to the beta cell
growth in human pregnancy? What is the identity of the pro-
genitor cells? Can identification of factors that promote beta
cell growth and function in pregnancy be useful in the treat-
ment or prevention of gestational diabetes and other forms
of diabetes?
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